March 24, 2025

Monica M. Bertagnolli, MD, FACS, FASCO, Joins Friends of Cancer Research Board of Directors

Friends of Cancer Research (Friends) is honored to announce the addition of former Director of the National Institutes of Health (NIH) Monica M. Bertagnolli, MD, FACS, FASCO, to its Board of Directors...

The ASCO Post

March 24, 2023

Studies of Novel Therapeutic Approaches Highlighted During Colorectal Cancer Awareness Month at Dana-Farber

The rise of colorectal cancer in those under 50 has spurred reevaluation of screening guidelines. Dr. Benjamin Schlechter is pioneering studies to explore novel treatment options, including next-generation immunotherapy drugs and CAR T-cell therapy, showing promising clinical activity.

The ASCO Post

July 19, 2024

Interaction of the Gut Microbiome With Cancer Treatment

Research finds that the gut microbiome has a significant impact on cancer pathogenesis and treatment responses, opening new avenues for improving cancer therapy outcomes.

JADPRO

September 28, 2023

Does Colon Tumor Location Play a Role in Metastasis and Survival?

A recent study examined survival outcomes among patients with right-sided vs left-sided colorectal tumors that had metastasized to the liver. The findings provide insight into the unique biology of ri...

The ASCO Post

March 24, 2023

100th robotic Ivor Lewis esophagectomy: Important milestone for complex procedure

Roswell Park’s Moshim Kukar, MD, recently completed his 100th robotic Ivor Lewis esophagectomy, an important milestone for this complex procedure. While robotic surgery is increasingly common for other types of operations, few centers have the surgical qualification and high-volume experience to offer robotic surgery for these difficult procedures

Roswell Park Comprehensive Cancer Center

November 13, 2023

FDA Approves Fruquintinib for Refractory Metastatic Colorectal Cancer

On November 8, the FDA approved an anti-VEGF tyrosine kinase inhibitor for adult patients with metastatic colorectal cancer who received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based che...

The ASCO Post

June 13, 2024

ADA calls for increased resources for Indian Health Service

The ADA is advocating for increased funding and resources for the Indian Health Service.

ADA News

March 06, 2024

Preventing Pancreatitis After ERCP

Johns Hopkins physician-researchers aim to make a key procedure safer.

Johns Hopkins Medicine

May 09, 2024

Pembrolizumab/Chemotherapy for Advanced Biliary Tract Cancer

Pembrolizumab (Keytruda) was recently approved for treating locally advanced unresectable or metastatic biliary tract cancer, showing promising results in improving overall and progression-free survival rates.

The ASCO Post